Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|October 8, 2021
Isolated Arthroscopic Partial Meniscectomy Is More Effective at Improving Meniscal Symptoms in Comparison With Mechanical Symptoms in Patients With Concomitant Untreated Chondral LesionsLeslie J Bisson, Melissa A Kluczynski, William M Wind, et al.
The Journal of Bone and Joint Surgery. American Volume|July 6, 2017
Patient Outcomes After Observation Versus Debridement of Unstable Chondral Lesions During Partial Meniscectomy: The Chondral Lesions And Meniscus Procedures (ChAMP) Randomized Controlled TrialLeslie J Bisson, Melissa A Kluczynski, William M Wind, et al.
Sexually Transmitted Diseases|August 16, 2019
Ceftriaxone Reduced Susceptible Neisseria gonorrhoeae in the Netherlands, 2009 to 2017: From PenA Mosaicism to A501T/V NonmosaicismMyrthe M de Laat, Carolien M Wind, Sylvia M Bruisten, et al.
European Heart Journal. Case Reports|October 30, 2019
Three female patients with Danon disease presenting with predominant cardiac phenotype: a case seriesBart A Mulder, Yvonne M Hoedemaekers, Maarten P van den Berg, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|July 15, 2021
Better Outcomes but No Difference in Joint Space Narrowing at Five Years Among Patients Without Unstable Chondral Lesions Versus Those With Unstable Chondral Lesions (Left In Situ) at the Time of Arthroscopic Partial MeniscectomyLeslie J Bisson, Melissa A Kluczynski, William M Wind, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2017
Decreased Azithromycin Susceptibility of Neisseria gonorrhoeae Isolates in Patients Recently Treated with AzithromycinCarolien M Wind, Esther de Vries, Maarten F Schim van der Loeff, et al.
The Lancet. Infectious Diseases|January 22, 2022
Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trialHenry J C de Vries, Myrthe de Laat, Vita W Jongen, et al.
Pageof 16